Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and analysis.
There will probably not be much of the government of German Chancellor Angela Merkel to adopt from Donald Trump, but it seems that she was struck by the treatment the former US president received when he was diagnosed with Covid-19 last year. .
Germany has bought 200,000 doses of monoclonal antibody drugs for $ 487 million and next week the country will be the first in the European Union to use it, Health Minister Jens Spahn told the Sunday edition of the newspaper Bild.
“Injecting these antibodies can help prevent patients at risk in the early stages from developing a serious condition,” he said. The German Ministry of Health did not immediately respond to Bloomberg’s request for comment.
Trump received experimental treatment from Regeneron Pharmaceutical Inc. in October after he was diagnosed with Covid-19. The then president was so impressed that he said he wanted to get it available for free to Americans, which ultimately did not happen. At least some of the doses ordered by Germany also come from Regeneron, according to DPA newswire.
Spahn, one of Merkel’s possible successors, has recently come under political pressure due to the slow development of the German vaccination program in Germany. According to the Robert Koch Institute, 1.63 million Germans have been vaccinated so far, accounting for less than 2% of the country’s total population.